SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.

Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hematogenous murine infection caused by two C. krusei...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Karyotakis, N C, Dignani, M C, Anaissie, E J
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1995
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.775
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!